Evidence map›Paper›PMID 36153315›Full record

ArticleNature communications2022

Lactobacillus supports Clostridiales to restrict gut colonization by multidrug-resistant Enterobacteriaceae.

Ana Djukovic, María José Garzón, Cécile Canlet, Vitor Cabral, Rym Lalaoui, Marc García-Garcerá, Julia Rechenberger, Marie Tremblay-Franco, Iván Peñaranda, Leonor Puchades-Carrasco and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 79 citations in OpenAlex.

  1. Trial
  2. Virulence · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Polysaccharide fromFoods (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Combined treatment withFrontiers in pharmacology · 2026
    Article
  10. Review
  11. Article
  12. Article
  13. Gut microbes · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Microorganisms · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 12 institutions in 6 countries.

Ana DjukovicFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.ORCID 0000-0001-8068-7188
María José GarzónFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.ORCID 0000-0002-9136-1236
Cécile Canlet *Toxalim - Research Center in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.
Vitor Cabral *Instituto Gulbenkian de Ciência, Oeiras, Portugal.
Rym Lalaoui *Aix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Marc García-Garcerá *Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland.ORCID 0000-0001-6408-7561
Julia Rechenberger *Chair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID 0000-0003-4189-3434
Marie Tremblay-FrancoToxalim - Research Center in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.
Iván PeñarandaFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain.
Leonor Puchades-CarrascoDrug Discovery Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.ORCID 0000-0003-0340-7458
Antonio Pineda-LucenaDrug Discovery Unit, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
Eva María González-BarberáHospital Universitari i Politècnic La Fe, Valencia, Spain.
Miguel SalavertHospital Universitari i Politècnic La Fe, Valencia, Spain.
José Luis López-HontangasHospital Universitari i Politècnic La Fe, Valencia, Spain.
Miguel Á SanzInstituto de Investigación Sanitaria La Fe, Valencia, Spain.ORCID 0000-0003-1489-1177
Jaime SanzHospital Universitari i Politècnic La Fe, Valencia, Spain.
Bernhard KusterChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID 0000-0002-9094-1677
Jean-Marc RolainAix Marseille Univ, IRD, APHM, MEPHI, IHU-Méditerranée Infection, Marseille, France.
Laurent DebrauwerToxalim - Research Center in Food Toxicology, Toulouse University, INRAE UMR 1331, ENVT, INP-Purpan, Paul Sabatier University, Toulouse, France.
Karina B XavierInstituto Gulbenkian de Ciência, Oeiras, Portugal.ORCID 0000-0001-5210-1434
Joao B XavierComputational and Systems Biology Program, Sloan-Kettering Institute, New York, NY, USA.ORCID 0000-0003-3592-1689
Carles UbedaFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana - FISABIO, Valencia, Spain. ubeda_carmor@gva.es.ORCID 0000-0003-0560-4658
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHospital Universitari i Politècnic La Fe · ESUniversité Toulouse III - Paul Sabatier · FRInstituto de Investigación Sanitaria Aragón · ESInstituto Gulbenkian de Ciência · PTMéditerranée Infection Foundation · FRTechnical University of Munich · DEInstituto de Investigación Sanitaria La Fe · ESInstituto de Salud Carlos III · ESKettering University · USMemorial Sloan Kettering Cancer Center · USUniversity of Lausanne · CH

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Mathematical ecology models of host-microbiota interaction in auto microbiota transplants (auto-FMT)R01AI137269 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI TAUR, YING, XAVIER, JOAO · 2019 to 2023
$3.8M
NCI NIH HHS P30 CA008748NIAID NIH HHS R01 AI137269
6 · The paper itself

Abstract

Infections by multidrug-resistant Enterobacteriaceae (MRE) are life-threatening to patients. The intestinal microbiome protects against MRE colonization, but antibiotics cause collateral damage to commensals and open the way to colonization and subsequent infection. Despite the significance of this problem, the specific commensals and mechanisms that restrict MRE colonization remain largely unknown. Here, by performing a multi-omic prospective study of hospitalized patients combined with mice experiments, we find that Lactobacillus is key, though not sufficient, to restrict MRE gut colonization. Lactobacillus rhamnosus and murinus increase the levels of Clostridiales bacteria, which induces a hostile environment for MRE growth through increased butyrate levels and reduced nutrient sources. This mechanism of colonization resistance, an interaction between Lactobacillus spp. and Clostridiales involving cooperation between microbiota members, is conserved in mice and patients. These results stress the importance of exploiting microbiome interactions for developing effective probiotics that prevent infections in hospitalized patients.

Indexed as

EnterobacteriaceaeLactobacillusAnimalsAnti-Bacterial AgentsButyratesEubacterialesMiceProspective StudiesAnti-Bacterial AgentsButyrates

Identifiers

PMID36153315
PMCPMC9509339
OpenAlexW4296977295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.